BIOGEN INC. Payments to Acquire Productive Assets
BIOGEN INC. (BIIB) reported Payments to Acquire Productive Assets of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2020-02-06
- BIOGEN INC. payments to acquire productive assets for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- BIOGEN INC. payments to acquire productive assets for fiscal 2018 was $58.20M, a 1840.00% increase from fiscal 2017.
- BIOGEN INC. payments to acquire productive assets for fiscal 2017 was $3.00M, a 92.23% decline from fiscal 2016.
- BIOGEN INC. payments to acquire productive assets for fiscal 2016 was $38.60M, a 194.66% increase from fiscal 2015.
| Period end | Payments to Acquire Productive Assets 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-06 |
| 2018-12-31 | $58.20M 10-K · filed 2020-02-06 |
| 2017-12-31 | $3.00M 10-K · filed 2020-02-06 |
| 2016-12-31 | $38.60M 10-K · filed 2019-02-06 |
| 2015-12-31 | $13.10M 10-K · filed 2018-02-01 |
| 2014-12-31 | $20.50M 10-K · filed 2017-02-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |